Literature DB >> 10523820

Alterations of hippocampal secreted N-CAM in bipolar disorder and synaptophysin in schizophrenia.

M P Vawter1, A L Howard, T M Hyde, J E Kleinman, W J Freed.   

Abstract

Schizophrenia and bipolar disorder have both been linked to structural abnormalities of the hippocampus, which is consistent with a neurodevelopmental anomaly. One isoform of the neural cell adhesion molecule (N-CAM) protein, cytosolic N-CAM 105-115 kDa, was previously shown to be increased in schizophrenia in the hippocampus and prefrontal cortex. Another isoform of N-CAM, the variable alternative spliced exon of N-CAM, was also increased in the hippocampus and prefrontal cortex of bipolar disorder patients. In the present study, the secreted isoform of N-CAM (SEC N-CAM), synaptophysin, and actin proteins were measured in the hippocampus of controls, suicide victims, and patients with bipolar disorder or schizophrenia by quantitative Western immunoblotting. Previous measurements of cytosolic N-CAM (105-115 kDa) protein, from the same hippocampus samples, were used to calculate the N-CAM (105-115 kDa)/synaptophysin ratio. An affinity purified antibody to SEC N-CAM recognized SEC N-CAM (108 kDa and 115 kDa) in brain but SEC N-CAM was not detectable in CSF. In bipolar disorder, but not in schizophrenia, an increased SEC N-CAM 115 kDa/108 kDa ratio was found as compared to controls (P = 0.03). The synaptophysin/actin ratio was significantly decreased in schizophrenia (P = 0.014) as compared to controls. The cytosolic N-CAM 105-115 kDa/synaptophysin ratio was increased in patients with schizophrenia (P= 0.017), but not in bipolar disorder. Thus, bipolar disorder patients show altered expression of SEC N-CAM in the hippocampus. Patients with schizophrenia show a decrease in synaptophysin and an increase in the cytosolic N-CAM 105-115 kDa/synaptophysin ratio. The results offer further evidence of differences in protein expression between bipolar disorder and schizophrenia in the hippocampus, which is consistent with a distinct neuropathology for each neuropsychiatric disorder.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523820     DOI: 10.1038/sj.mp.4000547

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  14 in total

Review 1.  The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors:  Paul J Harrison
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

2.  Synaptophysin regulates activity-dependent synapse formation in cultured hippocampal neurons.

Authors:  Leila Tarsa; Yukiko Goda
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

3.  Structural Features of Transcription Factors Associating with Nucleosome Binding.

Authors:  Meilin Fernandez Garcia; Cedric D Moore; Katharine N Schulz; Oscar Alberto; Greg Donague; Melissa M Harrison; Heng Zhu; Kenneth S Zaret
Journal:  Mol Cell       Date:  2019-07-11       Impact factor: 17.970

4.  Alterations in brain synaptic proteins and mRNAs in mood disorders: a systematic review and meta-analysis of postmortem brain studies.

Authors:  Edison Leung; Ethan W Lau; Andi Liang; Constanza de Dios; Robert Suchting; Linda Östlundh; Joseph C Masdeu; Masahiro Fujita; Marsal Sanches; Jair C Soares; Sudhakar Selvaraj
Journal:  Mol Psychiatry       Date:  2022-01-13       Impact factor: 13.437

5.  Developmental regulation of neural cell adhesion molecule in human prefrontal cortex.

Authors:  E T Cox; L H Brennaman; K L Gable; R M Hamer; L A Glantz; A-S Lamantia; J A Lieberman; J H Gilmore; P F Maness; L F Jarskog
Journal:  Neuroscience       Date:  2009-04-22       Impact factor: 3.590

6.  Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia.

Authors:  Chijioke N Egbujo; Duncan Sinclair; Karin E Borgmann-Winter; Steven E Arnold; Bruce I Turetsky; Chang-Gyu Hahn
Journal:  Schizophr Res       Date:  2015-08-07       Impact factor: 4.939

7.  NCAM1 association study of bipolar disorder and schizophrenia: polymorphisms and alternatively spliced isoforms lead to similarities and differences.

Authors:  Mary E Atz; Brandi Rollins; Marquis P Vawter
Journal:  Psychiatr Genet       Date:  2007-04       Impact factor: 2.458

8.  Schizophrenia proteomics: biomarkers on the path to laboratory medicine?

Authors:  Shaheen Emmanuel Lakhan
Journal:  Diagn Pathol       Date:  2006-07-17       Impact factor: 2.644

9.  NCAM promotes assembly and activity-dependent remodeling of the postsynaptic signaling complex.

Authors:  Vladimir Sytnyk; Iryna Leshchyns'ka; Alexander G Nikonenko; Melitta Schachner
Journal:  J Cell Biol       Date:  2006-09-25       Impact factor: 10.539

Review 10.  Intercellular protein-protein interactions at synapses.

Authors:  Xiaofei Yang; Dongmei Hou; Wei Jiang; Chen Zhang
Journal:  Protein Cell       Date:  2014-04-23       Impact factor: 14.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.